| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8603850 | The American Journal of Medicine | 2018 | 8 Pages |
Abstract
On the basis of the results of this meta-analysis, co-administration of DOACs and amiodarone, a dual P-gp/CYP3A4 inhibitor, does not seem to affect efficacy or safety outcomes in patients with atrial fibrillation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Florentino MD, Jorge MD, Bradley MD, Carola MD, David MD, Pedro MD, Kevin MD, Jay N. MD, Soo MD, John MD, Luigi MD, PhD, Andrew MD,